Drug Type Degradable Molecular Glue |
Synonyms AMP-TEAD-G01 |
Target |
Action inhibitors, degraders |
Mechanism FBXO22 inhibitors(F-box protein 22 inhibitors), TEAD degraders(TEA domain transcription factors degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Liver Cancer | Preclinical | United Kingdom | 25 Apr 2026 | |
| Mesothelioma | Preclinical | United Kingdom | 21 Apr 2026 | |
| Non-Small Cell Lung Cancer | Preclinical | United Kingdom | 21 Apr 2026 |





